Allogeneic hematopoietic cell transplantation after prior targeted therapy for high-risk chronic lymphocytic leukemia

Allogeneic hematopoietic cell transplantation (alloHCT) can cure previously treated high-risk chronic lymphocytic leukemia (CLL) patients if they are suitable for transplant through the graft-versus-leukemia effect. However, since the emergence of targeted therapies, the role of alloHCT for high-ris...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Main Authors: Kim, Haesook T., Shaughnessy, Conner J., Rai, Sharmila C., Reynolds, Carol, Ho, Vincent T., Cutler, Corey, Koreth, John, Gooptu, Mahasweta, Romee, Rizwan, Nikiforow, Sarah, Armand, Philippe, Alyea, Edwin P., Antin, Joseph H., Wu, Catherine J., Soiffer, Robert J., Ritz, Jerome, Brown, Jennifer R.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2020
Assuntos:
Transplantation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479951/
https://ncbi.nlm.nih.gov/pubmed/32882002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002184
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados